Literature DB >> 1498578

Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease.

R Henderson1, R Kurlan, J M Kersun, P Como.   

Abstract

Significant anxiety in combination with depression may represent a specific depressive subtype in Parkinson's disease (PD). To ascertain the prevalence of this symptom complex, we administered a self-report survey and standardized psychological tests that measure anxiety and depression to 164 PD patients and 150 age-matched healthy spouse control subjects. The reporting of depression in combination with panic/anxiety best differentiated the two populations (38% vs. 8%). Depression and anxiety were highly correlated in relationship to clinical features of PD. Our findings suggest that clinically significant levels of depression and anxiety may frequently coexist in PD. The specific neuropathology of PD may predispose to this pattern of behavioral disturbance.

Entities:  

Mesh:

Year:  1992        PMID: 1498578     DOI: 10.1176/jnp.4.3.257

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  25 in total

1.  Depression in Parkinson's disease.

Authors:  H Allain; S Schuck; N Mauduit
Journal:  BMJ       Date:  2000-05-13

2.  Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.

Authors:  Gregory M Pontone; James R Williams; Karen E Anderson; Gary Chase; Susanne A Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Peter V Rabins; Howard D Weiss; Laura Marsh
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

Review 3.  Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease.

Authors:  Atami Sagna; Joseph J Gallo; Gregory M Pontone
Journal:  Parkinsonism Relat Disord       Date:  2014-04-01       Impact factor: 4.891

4.  Paraventricular hypothalamic and amygdalar CRF neurons synapse in the external globus pallidus.

Authors:  Albert J Hunt; Rajan Dasgupta; Shivakumar Rajamanickam; Zhiying Jiang; Michael Beierlein; C Savio Chan; Nicholas J Justice
Journal:  Brain Struct Funct       Date:  2018-03-23       Impact factor: 3.270

5.  Anxiety and self-perceived health status in Parkinson's disease.

Authors:  Gregory M Pontone; James R Williams; Karen E Anderson; Gary Chase; Susanne R Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Peter V Rabins; Howard D Weiss; Laura Marsh
Journal:  Parkinsonism Relat Disord       Date:  2011-02-02       Impact factor: 4.891

6.  Prevalence of problem and pathological gambling in Parkinson's disease.

Authors:  David Crockford; Jeremy Quickfall; Shawn Currie; Sarah Furtado; Oksana Suchowersky; Nady El-Guebaly
Journal:  J Gambl Stud       Date:  2008-06-17

Review 7.  Parkinson's disease and anxiety.

Authors:  K Walsh; G Bennett
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

8.  Parkinson's disease: genetics and beyond.

Authors:  N N Inamdar; D K Arulmozhi; A Tandon; S L Bodhankar
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

Review 9.  Treatment of depression in Parkinson's disease.

Authors:  Matthew Menza; Roseanne DeFronzo Dobkin; Humberto Marin
Journal:  Curr Psychiatry Rep       Date:  2006-06       Impact factor: 5.285

10.  Evaluation of anxiety in Parkinson's disease with some commonly used rating scales.

Authors:  F Mondolo; M Jahanshahi; A Granà; E Biasutti; E Cacciatori; P Di Benedetto
Journal:  Neurol Sci       Date:  2007-10-31       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.